) The Cytogenetics Core offers state-of-the-art cytogenetic technology for Cancer Center members. Banding karyotype is available for numerous mammalian species and computer-based karyotyping is provided for human cells. Among the molecular techniques available, fluorescence in situ (FISH) analysis is offered in metaphase and interphase cells for single or multiple DNA targets from a variety of biological specimens. Comparative Genomic Hybridization (for human, mouse and rat specimens) and multicolor karyotyping (Multiplex-FISH) are also available. In addition to the use of commercial probes, the Cytogenetics Core has capability to prepare DNA probes according to the investigator?s needs. Scientific and technical support has been provided to Cancer Center members in experimental design of projects and a comprehensive interpretation of the data obtained in the assays is offered. A total of 31 Cancer Center members from 9 distinct Programs (Cell Biology, Tobacco Related Malignancies, Cancer Genetics, Developmental Therapeutics, Hormone Related Malignancies, Immunology and Immunotherapy, Carcinogenesis and Chemoprevention, and Pediatric Oncology), have used this facility from 1996 to 1999. Approximately 50% of the investigators have used the Core for more than a grant-year. On average, more than 1,000 procedures were performed per year, and a dramatic change from classical towards molecular techniques has been observed. The Core has been assisting Cancer Center investigators both in basic and translational aspects of cancer research. The development of new FISH probes, such as the 3p21.31 probe that usually detects deletion in lung carcinomas, the D-FISH AML/ETO probe for diagnosis of residual AML-M2, and the E2A probe for ALL, illustrates the translational focus of projects that make use of the laboratory. Mapping of DNA clones, characterization and analysis of chromosomal evolution of cell lines, identification of subtle heterozygous and homozygous deletions, and detection of gene amplifications are examples of services routinely submitted to the Core.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA046934-15
Application #
6589969
Study Section
Project Start
2002-05-06
Project End
2003-01-31
Budget Start
Budget End
Support Year
15
Fiscal Year
2002
Total Cost
$250,404
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
New, Melissa L; White, Collin M; McGonigle, Polly et al. (2018) Prostacyclin and EMT Pathway Markers for Monitoring Response to Lung Cancer Chemoprevention. Cancer Prev Res (Phila) 11:643-654
Vartuli, Rebecca L; Zhou, Hengbo; Zhang, Lingdi et al. (2018) Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation. J Clin Invest 128:2535-2550
Scott, Aaron J; Arcaroli, John J; Bagby, Stacey M et al. (2018) Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms. Mol Cancer Ther 17:2112-2122
da Silva, Raquel Frenedoso; Dhar, Deepanshi; Raina, Komal et al. (2018) Nintedanib inhibits growth of human prostate carcinoma cells by modulating both cell cycle and angiogenesis regulators. Sci Rep 8:9540
Majtan, Tomas; Jones Jr, Wendell; Krijt, Jakub et al. (2018) Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria. Mol Ther 26:834-844
Dhar, Deepanshi; Deep, Gagan; Kumar, Sushil et al. (2018) Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells. Mol Carcinog 57:1166-1180
Donson, Andrew M; Amani, Vladimir; Warner, Elliot A et al. (2018) Identification of FDA-Approved Oncology Drugs with Selective Potency in High-Risk Childhood Ependymoma. Mol Cancer Ther 17:1984-1994
Branchford, B R; Stalker, T J; Law, L et al. (2018) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. J Thromb Haemost 16:352-363
Pei, Shanshan; Minhajuddin, Mohammad; Adane, Biniam et al. (2018) AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells. Cell Stem Cell 23:86-100.e6
Ren, Shengxiang; Rivard, Christopher J; Yu, Hui et al. (2018) A miRNA Panel Predicts Sensitivity of FGFR Inhibitor in Lung Cancer Cell Lines. Clin Lung Cancer 19:450-456

Showing the most recent 10 out of 1634 publications